{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:04:42Z","timestamp":1784192682967,"version":"3.55.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"13-14","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00508-025-02682-9","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T13:58:13Z","timestamp":1766411893000},"page":"444-448","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Systemic lupus erythematosus combined with Castleman disease: a\u00a0case report"],"prefix":"10.1007","volume":"138","author":[{"given":"Man","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohua","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"issue":"24","key":"2682_CR1","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1001\/jama.2024.2315","volume":"331","author":"CH Siegel","year":"2024","unstructured":"Siegel\u00a0CH, Sammaritano\u00a0LR. Systemic lupus Erythematosus: a\u00a0review. Jama\u2011j Am Med Assoc. 2024;331(24):1480\u201391.","journal-title":"Jama-j Am Med Assoc"},{"issue":"4","key":"2682_CR2","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1046\/j.1440-1827.2000.01052.x","volume":"50","author":"M Kojima","year":"2000","unstructured":"Kojima\u00a0M, Nakamura\u00a0S, Morishita\u00a0Y, Itoh\u00a0H, Yoshida\u00a0K, Ohno\u00a0Y, et\u00a0al. Reactive follicular hyperplasia in the lymph node lesions from systemic lupus erythematosus patients: a\u00a0clinicopathological and immunohistological study of 21\u00a0cases. Pathol Int. 2000;50(4):304\u201312.","journal-title":"Pathol Int"},{"issue":"1","key":"2682_CR3","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s13075-021-02648-y","volume":"23","author":"J Han","year":"2021","unstructured":"Han\u00a0J, Kim\u00a0H, Jung\u00a0S, Jang\u00a0EJ, Cho\u00a0S, Sung\u00a0Y. Increased risk of malignancy in patients with systemic lupus erythematosus: population-based cohort study in korea. Arthritis Res Ther. 2021;23(1):270.","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"2682_CR4","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1179\/acb.2004.023","volume":"59","author":"K Van de Voorde","year":"2004","unstructured":"Van de Voorde\u00a0K, De Raeve\u00a0H, Block\u00a0CE, Van Regenmortel\u00a0N, Van Offel\u00a0JF, De Clerck\u00a0LS, et\u00a0al. Atypical systemic lupus erythematosus or Castleman\u2019s disease. Acta Clin Belg. 2004;59(3):161\u20134.","journal-title":"Acta Clin Belg"},{"issue":"1","key":"2682_CR5","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12969-023-00871-2","volume":"21","author":"X Ma","year":"2023","unstructured":"Ma\u00a0X, Li\u00a0J, Fan\u00a0L, Jiang\u00a0H, Shi\u00a0G, Ge\u00a0D, et\u00a0al. Systemic lupus erythematosus combined with Castleman disease and secondary paraneoplastic pemphigus: a\u00a0case report. Pediatr Rheumatol. 2023;21(1):126.","journal-title":"Pediatr Rheumatol"},{"key":"2682_CR6","doi-asserted-by":"publisher","first-page":"2050313X2211061","DOI":"10.1177\/2050313X221106110","volume":"10","author":"K Gunathilake","year":"2022","unstructured":"Gunathilake\u00a0K, Rifath\u00a0M, Munasinghe\u00a0BM, Muhunthiny\u00a0P, Vincent\u00a0G. Systemic lupus erythematosus mimicking idiopathic multicentric Castleman disease: a\u00a0diagnostic dilemma. Sage Open Med Case\u00a0R. 2022;10:2050313X221106110.","journal-title":"Sage Open Med Case R"},{"issue":"12","key":"2682_CR7","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1182\/blood-2016-10-746933","volume":"129","author":"DC Fajgenbaum","year":"2017","unstructured":"Fajgenbaum\u00a0DC, Uldrick\u00a0TS, Bagg\u00a0A, Frank\u00a0D, Wu\u00a0D, Srkalovic\u00a0G, et\u00a0al. International, evidence-based consensus diagnostic criteria for HHV-8-negative\/idiopathic multicentric Castleman disease. Blood. 2017;129(12):1646\u201357.","journal-title":"Blood"},{"issue":"23","key":"2682_CR8","doi-asserted-by":"publisher","first-page":"6039","DOI":"10.1182\/bloodadvances.2020003334","volume":"4","author":"F van Rhee","year":"2020","unstructured":"van Rhee\u00a0F, Oksenhendler\u00a0E, Srkalovic\u00a0G, Voorhees\u00a0P, Lim\u00a0M, Dispenzieri\u00a0A, et\u00a0al. International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease. Blood Adv. 2020;4(23):6039\u201350.","journal-title":"Blood Adv"},{"issue":"9","key":"2682_CR9","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1080\/1744666X.2024.2357689","volume":"20","author":"S Tsunoda","year":"2024","unstructured":"Tsunoda\u00a0S, Harada\u00a0T, Kikushige\u00a0Y, Kishimoto\u00a0T, Yoshizaki\u00a0K. Immunology and targeted therapy in castleman disease. Expert Rev Clin Immu. 2024;20(9):1101\u201312.","journal-title":"Expert Rev Clin Immu"},{"issue":"6","key":"2682_CR10","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.prp.2007.03.002","volume":"203","author":"M Kojima","year":"2007","unstructured":"Kojima\u00a0M, Motoori\u00a0T, Asano\u00a0S, Nakamura\u00a0S. Histological diversity of reactive and atypical proliferative lymph node lesions in systemic lupus erythematosus patients. Pathol Pract. 2007;203(6):423\u201331.","journal-title":"Pathol Pract"},{"key":"2682_CR11","doi-asserted-by":"publisher","first-page":"899073","DOI":"10.3389\/fimmu.2022.899073","volume":"13","author":"S Qian","year":"2022","unstructured":"Qian\u00a0S, Ding\u00a0M, Hou\u00a0H, Wang\u00a0Z, Zhang\u00a0J, Zhang\u00a0Y, et\u00a0al. Clinical and molecular characteristics of 60\u00a0patients with human Immunodeficiency virus-negative Castleman disease. Front Immunol. 2022;13:899073.","journal-title":"Front Immunol"},{"issue":"5","key":"2682_CR12","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1136\/jcp-2022-208696","volume":"77","author":"L Rodriguez Merino","year":"2024","unstructured":"Rodriguez Merino\u00a0L, Pomares\u00a0AA, Arce\u00a0JR, Montes-Moreno\u00a0S. From Castleman disease histopathological features to idiopathic multicentric castleman disease: a\u00a0multiparametric approach to exclude potential iMCD histopathological mimickers. J\u00a0Clin Pathol. 2024;77(5):318\u201323.","journal-title":"J Clin Pathol"},{"issue":"7","key":"2682_CR13","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1007\/s00432-020-03494-2","volume":"147","author":"D Sun","year":"2021","unstructured":"Sun\u00a0D, Chen\u00a0W, Wang\u00a0L, Wang\u00a0Z, Liang\u00a0J, Zhu\u00a0H, et\u00a0al. Clinical characteristics and immunological abnormalities of castleman disease complicated with autoimmune diseases. J\u00a0Cancer Res Clin. 2021;147(7):2107\u201315.","journal-title":"J Cancer Res Clin"},{"issue":"3","key":"2682_CR14","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/1097-0142(197203)29:3<670::AID-CNCR2820290321>3.0.CO;2-#","volume":"29","author":"AR Keller","year":"1972","unstructured":"Keller\u00a0AR, Hochholzer\u00a0L, Castleman\u00a0B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer. 1972;29(3):670\u201383.","journal-title":"Cancer"},{"issue":"1S","key":"2682_CR15","first-page":"S1","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO)","year":"2024","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO), Lupus Nephritis Work Group. KDIGO 2024 clinical practice guideline for the management of LUPUS NEPHRITIS. Kidney Int. 2024;105(1S):S1\u2013S69.","journal-title":"Kidney Int"},{"issue":"11","key":"2682_CR16","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1177\/0961203313502864","volume":"22","author":"CC Mok","year":"2013","unstructured":"Mok\u00a0CC, To\u00a0CH, Yu\u00a0KL, Ho\u00a0LY. Combined low-dose mycophenolate mofetil and tacrolimus for lupus nephritis with suboptimal response to standard therapy: a\u00a012-month prospective study. Lupus. 2013;22(11):1135\u201341.","journal-title":"Lupus"},{"issue":"9","key":"2682_CR17","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/S1470-2045(14)70319-5","volume":"15","author":"F an Rhee","year":"2014","unstructured":"an Rhee\u00a0F, Wong\u00a0RS, Munshi\u00a0N, Rossi\u00a0JF, Ke\u00a0XY, Foss\u00e5\u00a0A, et\u00a0al. Siltuximab for multicentric castleman\u2019s disease: a\u00a0randomised, double-blind, placebo-controlled trial. Lancet Oncol. 2014;15(9):966\u201374.","journal-title":"Lancet Oncol"},{"issue":"7","key":"2682_CR18","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1007\/s00296-010-1451-0","volume":"32","author":"J Xia","year":"2012","unstructured":"Xia\u00a0J, Chen\u00a0X, Xu\u00a0F, Yang\u00a0Y, Wang\u00a0H, Xue\u00a0J. A\u00a0case report of systemic lupus erythematosus combined with Castleman\u2019s disease and literature review. Rheumatol Int. 2012;32(7):2189\u201393.","journal-title":"Rheumatol Int"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-025-02682-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00508-025-02682-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-025-02682-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T08:24:44Z","timestamp":1784190284000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00508-025-02682-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":18,"journal-issue":{"issue":"13-14","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["2682"],"URL":"https:\/\/doi.org\/10.1007\/s00508-025-02682-9","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"20 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.\u00a0Luo, H.\u00a0He, L.\u00a0Chen, G.\u00a0Yuan, L.\u00a0Yang and F.\u00a0He declare that they have no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study involves a\u00a0human participant but Institutional Ethics Committee of Suining Central Hospital does not require board review for a\u00a0single case report when the patient\u2019s privacy is protected and therefore exempted this study (Approval number: KYLLMC20250006). Informed consent: the patient gave informed consent for the publication of this report and associated images. Written informed consent was obtained from the patients for participation in this study.","order":2,"name":"Ethics","label":"Ethical standards","group":{"name":"EthicsHeading","label":"Declarations"}}]}}